Johnson & Johnson's DePuy Synthes Sells Prodisc Assets for an Undisclosed Sum

Published: Sep 20, 2017

Centinel Spine has agreed to acquire Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes’ Prodisc assets for an undisclosed amount, according to an OrthoWorld report.

In the deal, DePuy is offloading its Prodisc-C, Prodisc-L, Prodisc-C Vivo, Prodisc-C Nova, Prodisc-O and Discover cervical and lumbar artificial disc systems to Centinel Spine, according to the report.

The Prodisc-C and Prodisc-L are the only 2 products which have approval in the US, according to OrthoWorld, and Centinel plans to launch clinical studies as it pursues FDA approval of the other devices it acquired.

Back to news